Enhanced Qualitative Mass Spectrometry Capabilities for Fast and Effective Identification of Metabolites
September 10, 2012 - Charles River has provided Qualitative Mass Spectrometry (QMS) for over 20 years, and we have developed our QMS services by recruiting and training staff in this highly specialized area and continually investing in our equipment and facilities. We believe it is important to have a variety of instrument types and to select the correct mass spectrometry experiment for each particular identification challenge.
In keeping with this commitment to providing the best QMS services, Charles River has recently invested in a Waters SYNAPT® G2-S to complement our existing Qualitative Mass Spectrometers (Waters QToF, Shimadzu IT-ToF and AB SCIEX Triple Quad™ instruments) and to further develop our structural elucidation services.
In addition to accurate mass and high resolution, the Waters SYNAPT® G2-S also provides Ion Mobility Separation (IMS), which allows the separation of isomeric entities based on their cross-sectional area as well as charge. These enhanced features, along with software modeling of cross-sectional areas, will provide the capability to direct synthetic efforts in producing reference standards required for regulatory studies.
This technology has the potential to provide data that would not otherwise be available, as well as reduce the time and effort required to isolate and characterize metabolites.
To learn more about our QMS capabilities, contact us at email@example.com.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
We have established an in vivo screening platform to provide fast and cost-effective screening of compound effects on motor behavior and brain functionality for the study for central nervous system diseases.
We offer a package of well-established, state of the art in vitro mode of action assays that are suitable for early phase biocomparability studies, lot release and stability. These tests can accelerate the time it takes to get a new product ready for market submission.
May 28–Jun 01
The International Bone and Mineral Society (IBMS) and the Japanese Society for Bone and Mineral Research (JSBMR) are excited to sponsor the second joint scientific meeting by the two organizations.
May 27–May 29
Charles River and the René Remie Surgical Skills Centre (RRSSC) have joined their expertise and are pleased to offer a 3-day surgery training course. Held at the RRSSC in the Netherlands, this training is designed to be very practical and combines lectures with hands-on exercises, ensuring you receive the most comprehensive training experience. This course is recommended for simple procedures only (e.g., simple exeresis, simple catheterizations such as jugular vein or femoral vein, simple ALZET pump implantation, ECG radiotelemetry).
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.